W
Wei-Chieh Cheng
Researcher at Academia Sinica
Publications - 71
Citations - 2903
Wei-Chieh Cheng is an academic researcher from Academia Sinica. The author has contributed to research in topics: Lipid II & Moiety. The author has an hindex of 26, co-authored 69 publications receiving 2585 citations. Previous affiliations of Wei-Chieh Cheng include Scripps Research Institute & National Taiwan University.
Papers
More filters
Journal ArticleDOI
Chemical chaperones increase the cellular activity of N370S β-glucosidase: A therapeutic strategy for Gaucher disease
Anu R. Sawkar,Wei-Chieh Cheng,Ernest Beutler,Chi-Huey Wong,William E. Balch,Jeffery W. Kelly +5 more
TL;DR: It is proposed that NN-DNJ chaperones β-Glu folding at neutral pH allows the stabilized enzyme to transit from the endoplasmic reticulum to the Golgi, enabling proper trafficking to the lysosome.
Journal ArticleDOI
Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P 1 antagonist in vivo
M. Germana Sanna,Sheng-Kai Wang,Pedro J. Gonzalez-Cabrera,Pedro J. Gonzalez-Cabrera,Anthony S. Don,David Marsolais,Melanie P. Matheu,Sindy H. Wei,Ian Parker,Euijung Jo,Wei-Chieh Cheng,Michael D. Cahalan,Chi-Huey Wong,Hugh Rosen +13 more
TL;DR: Chemical modulation reveals differences in S1P-S1P1 'set points' among tissues and highlights both mechanistic advantages (lymphocyte sequestration) and risks (pulmonary edema) of therapeutic intervention.
Journal ArticleDOI
Gaucher Disease-Associated Glucocerebrosidases Show Mutation-Dependent Chemical Chaperoning Profiles
Anu R. Sawkar,Sara L. Adamski-Werner,Wei-Chieh Cheng,Chi-Huey Wong,Ernest Beutler,Klaus-Peter Zimmer,Jeffery W. Kelly +6 more
TL;DR: It is demonstrated that G202R, a glucocerebrosidase variant that is known to be retained in the endoplasmic reticulum, is also amenable to chemical chaperoning, and the L444P variant is not chaperoned by any of the active site-directed molecules tested, likely because this mutation destabilizes a domain distinct from the catalytic domain.
Journal ArticleDOI
Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli
Ming-Ta Sung,Yen-Ting Lai,Chia-Ying Huang,Lien-Yang Chou,Hao-Wei Shih,Wei-Chieh Cheng,Chi-Huey Wong,Che Ma +7 more
TL;DR: The X-ray crystal structure of the bifunctional transglycosylase penicillin-binding protein 1b from Escherichia coli in complex with its inhibitor moenomycin is determined to 2.16-Å resolution and reveals a domain for protein–protein interaction and a transmembrane helix domain essential for substrate binding, enzymatic activity, and membrane orientation.
Journal ArticleDOI
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection.
Jia Tsrong Jan,Ting-Jen R. Cheng,Yu Pu Juang,Hsiu Hua Ma,Ying-Ta Wu,Wen-Bin Yang,Cheng Wei Cheng,Xiaorui Chen,Ting Hung Chou,Jiun-Jie Shie,Wei-Chieh Cheng,Rong-Jie Chein,Shi Shan Mao,Pi-Hui Liang,Pi-Hui Liang,Che Ma,Shang-Cheng Hung,Chi-Huey Wong,Chi-Huey Wong +18 more
TL;DR: In this paper, the authors used a cell-based infection assay to screen more than 3,000 agents used in humans and animals, including 2,855 small molecules and 190 traditional herbal medicines, and identified 15 active small molecules in concentrations ranging from 0.1 nM to 50 μM.